STOCK MARKET BSE NSE

Fauci: US to spend USD 3.2 billion for antiviral pills for COVID-19

The pills for COVID-19, which would be used to minimize symptoms after infection, are in development and could begin arriving by year's end, pending the completion of clinical trials.

Published: 18th June 2021 12:41 AM  |   Last Updated: 18th June 2021 12:41 AM   |  A+A-

Dr Anthony Fauci

US medical expert Dr Anthony Fauci (File photo | AP)

By PTI

WASHINGTON: The United States is devoting $3.2 billion to advance development of antiviral pills for COVID-19 and other dangerous viruses that could turn into pandemics.

Dr.Anthony Fauci, the nation's top infectious disease expert, announced the investment Thursday at a White House briefing as part of a new “antiviral program for pandemics” to develop drugs to address symptoms caused by potentially dangerous viruses like the coronavirus.

The pills for COVID-19, which would be used to minimize symptoms after infection, are in development and could begin arriving by year's end, pending the completion of clinical trials.

The funding will speed those clinical trials and provide additional support to private sector research, development and manufacturing.

Fauci said the new program would invest in “accelerating things that are already in progress” for COVID-19 but also would work to innovate new therapies for other viruses.

“There are few treatments that exist for many of the viruses that have pandemic potential," he said.

But he added, “vaccines clearly remain the centerpiece of our arsenal.”

The US has approved one antiviral drug, remdesivir, against COVID-19 and allowed emergency use of three antibody combinations that help the immune system fight the virus.

But all the drugs have to be infused at hospitals or medical clinics, and demand has been low due to these logistical hurdles.

The US government has been trying to raise awareness of the treatments, connecting people who test positive for COVID-19 with information about nearby providers.

Health experts, including Fauci, have increasingly called for simpler pill-based drugs that patients could take themselves.

Some drugmakers are testing such medications, but initial results aren't expected for several more months.

The currently available drugs have mostly been shown to help patients avoid hospitalization or shorten their recovery time by several days.

Under President Donald Trump, the U.S. poured more than $19 billion into rapidly developing multiple vaccines.

But less than half that amount went toward developing new treatments.

That shortfall has become increasingly concerning as the vaccination campaign slows and experts emphasize the need to manage the disease in millions of Americans who may never get inoculated.

The biggest need is for a convenient pill that can help keep patients with early symptoms of COVID-19 from developing severe disease and needing hospitalization.

Several companies, including Pfizer, Roche and AstraZeneca, are testing antivirals in pill form.

Until this week, the only medicines shown to boost survival were steroids given to patients sick enough to need extra oxygen and intensive care.

But on Wednesday, U.

K.

researchers reported that one of the antibody combinations successfully reduced deaths in a large study of hospitalized COVID-19 patients.

News of the Biden administration's plans for the antiviral pills was first reported by The New York Times.

(AP) AMS 06172232 NNNN



Comments(2)

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

  • MV

    Oh... well... what about the already successful Ivermectin treatment?
    24 days ago reply
  • pro-truth

    there are already covid-19 treatments-ivermectin and HCQ. Fauci refuses to approve them because the big Pharm in the US won't make much money on them
    1 month ago reply
flipboard facebook twitter whatsapp